Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1′-CN-4-aza-7,9-dideazaadenosine C-nucleoside

Detalles Bibliográficos
Autores principales: Zhou, Qifan, Yang, Sidi, Cao, Liu, Yang, Yang, Xu, Tiefeng, Chen, Qishu, Lu, Hongzhou, Li, Yingjun, Guo, Deyin, Zhang, Xumu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835026/
https://www.ncbi.nlm.nih.gov/pubmed/36635259
http://dx.doi.org/10.1038/s41392-023-01310-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835026/
https://www.ncbi.nlm.nih.gov/pubmed/36635259
http://dx.doi.org/10.1038/s41392-023-01310-0

Ejemplares similares